Bill
S 2392
Increases veterans disability and survivor benefits by the same percentage as Social Security’s COLA starting December 1, 2025.
Note on bill number
- Multiple, unrelated measures use the identifier “S. 2392” in different legislatures (U.S. Senate, New Jersey Legislature, Massachusetts Legislature). The documents you provided describe at least three distinct bills. Below are concise, separate summaries for each bill/version found in the materials.
1) U.S. Senate — S. 2392 (Veterans’ Compensation Cost‑of‑Living Adjustment Act of 2025)
- Purpose and intent
- Increase disability compensation rates for veterans with service‑connected disabilities and increase dependency and indemnity compensation (DIC) for survivors, effective December 1, 2025, to reflect the same percentage increase applied to Social Security benefits (the SSA COLA).
- Key provisions
- Raises the dollar amounts in current law (e.g., 38 U.S.C. §1114 wartime disability compensation, §1162 clothing allowance, §§1311–1314 DIC amounts to surviving spouse/children, and related statutory amounts) by the same percentage as the Social Security benefit increase effective December 1, 2025 (per 42 U.S.C. §415(i)).
- Authorizes the Secretary of Veterans Affairs to make administrative adjustments consistent with the increases (including certain historic beneficiaries under Pub. L. 85–857).
- Requires publication in the Federal Register of the adjusted amounts by the timeframe tied to Social Security’s publication requirements.
- Affected parties
- Veterans receiving service‑connected disability compensation, surviving spouses/children receiving DIC, and certain other beneficiaries paid under specified statutes.
- Procedural/timeline notes
- Introduced July 23, 2025 (Sen. Moran et al.); reported favorably by the Senate Committee on Veterans’ Affairs; placed on Senate calendar (Calendar No. 202); passed the Senate (unanimous consent on 11/9/2025); transmitted to the House. Effective date for increases: December 1, 2025.
2) New Jersey Senate No. 2392 — Expand qualifying condition for medical cannabis to include sickle cell anemia
- Purpose and intent
- Add sickle cell anemia (sickle cell disease) to the list of qualifying medical conditions for New Jersey’s Medicinal Cannabis Program so patients with that diagnosis may register and access medical cannabis.
- Key provisions & changes
- Amends relevant state medical cannabis statute/regulations to include sickle cell disease as a qualifying condition.
- Leaves program structure intact; patients would register with the Cannabis Regulatory Commission and follow existing program rules.
- Fiscal impact (Office of Legislative Services fiscal note, Nov. 24, 2025)
- State expenditures: indeterminate but marginal increase for the Cannabis Regulatory Commission to regulate expanded participation (program infrastructure already established; NJ had ~64,000 registered patients in 2024).
- State revenues: up to $14,200 annually maximum from $10 physical ID card fee for newly-registered and renewing sickle cell patients and caregivers (less if participants choose free digital IDs). Assumes ~33.3% of eligible sickle cell patients/caregivers register per year; registrations renew every two years.
- Affected parties
- New Jersey residents diagnosed with sickle cell anemia, their designated caregivers, and medical cannabis program administrators and dispensaries.
- Procedural/timeline notes
- Reported favorably by the Senate Health, Human Services & Senior Citizens Committee (Nov. 13, 2025). Fiscal estimate prepared by OLS. (This is a state bill; the file includes amended statutory language excerpts.)
3) Massachusetts Senate Docket No. 2392 — Expand MBTA “The Ride” eligibility for medical trips
- Purpose and intent
- Require the Massachusetts Bay Transportation Authority (MBTA) to make “The Ride” paratransit services available to residents of communities within 25 miles of Boston for medical‑related trips to Boston.
- Key provisions
- Adds a section to Chapter 161A directing MBTA to serve people living within 25 miles of Boston for medical purposes.
- Requires the Commonwealth Health Insurance Connector Board to reimburse the MBTA for the costs of providing those expanded services.
- Affected parties
- MBTA (“The Ride”) users who live up to 25 miles from Boston and need transportation to Boston for medical reasons; MBTA and the Health Connector (financially).
- Procedural note
- Filed Jan. 17, 2025; assigned to Transportation.
Discrepancy: “Allows certain members of a public body to be counted as present for quorum purposes at meetings attended remotely”
- The title you listed at the top (remote quorum attendance) does not match the substantive text in the documents provided. I found no supporting text or fiscal note for that topic among the supplied documents. If you intended a summary of a remote‑quorum/virtual meeting bill, please provide the bill text or clarify the jurisdiction and I will prepare a focused summary.
Would you like a deeper dive on any one of these (full bill text analysis, predicted fiscal/administrative impacts, or comparison to related legislation)?
Compiled from official sources — confirm details with the bill’s official record.
Sign in to ask a question.
